Showing results (161-170 of 259) with videos related to

Sort By:
Pageof 26
Endocrine-Related Cancer|September 7, 2006
Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancerDaniele Generali, Stephen B Fox, Alfredo Berruti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancerDaniele Generali, Francesca M Buffa, Alfredo Berruti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patientsDaniele Generali, Gaynor Bates, Alfredo Berruti, et al.
Nutrients|September 14, 2024
The Protective Effects of an Aged Black Garlic Water Extract on the ProstateMaria Loreta Libero, Antonio J Montero-Hidalgo, Lucia Recinella, et al.
Biomedicines|February 25, 2023
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center ReportNavid Sobhani, Victoria Bouchè, Giovanni Aldegheri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancerDaniele Generali, Stephen B Fox, Maria Pia Brizzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2023
Comparative Genomic Profiling of Second Breast Cancers following First Ipsilateral Hormone Receptor-Positive Breast CancersElie Rassy, Ingrid Garberis, Alicia Tran-Dien, et al.
Breast (Edinburgh, Scotland)|May 30, 2024
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional studyFrancesco Schettini, Silvana Saracchini, Anna Bassini, et al.
Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.
Pageof 26